HRAS and neoplasm: Additionally, 5 new mutations were exclusively detected in the recurrent tumor sample: FLT3 (c.2498C>G), CDKN2A (c.172C>T), KIT (c.1640A>G), TP53 (c.406delC), HRAS (c.38G>T).